Skip to main content
Erschienen in: Rheumatology International 10/2007

01.08.2007 | Original Article

The role of chemokines in Henoch Schonlein Purpura

verfasst von: Fulya Tahan, Ismail Dursun, Hakan Poyrazoglu, Metin Gurgoze, Ruhan Dusunsel

Erschienen in: Rheumatology International | Ausgabe 10/2007

Einloggen, um Zugang zu erhalten

Abstract

Background

The pathogenesis of Henoch Schonlein Purpura is incompletely understood and the role of chemokines is unknown.

Objective

To investigate the levels of CC chemokines, eotaxin, TARC, and CXC chemokine IP-10 in Henoch Schonlein Purpura.

Methods

Three groups of children were enrolled in the study: Henoch Schonlein Purpura in active stage (n = 26), Henoch Schonlein Purpura in remission phase (n = 26) and healthy children (n = 18). Levels of eotaxin, TARC, and IP-10 were determined in plasma using ELISA.

Results

No significant difference was observed in the plasma level of eotaxin and TARC levels between the HSP and healthy children (>0.05). We could not find any significant difference between acute phase of the disease and convalescent phase in eotaxin and TARC levels (P > 0.05). We have suggested significant decreases in plasma IP-10 in the acute phase of the disease compared with the convalescent phase (P < 0.05). There was a significant difference in IP-10 levels between active stage and healthy controls, too (<0.05). We could not find any significant correlation between chemokine levels and system involvement (>0.05).

Conclusion

Our study shows that plasma level of eotaxin and TARC levels do not differ between the HSP and healthy children. But, decreasing the release of the Th1 chemokine IP-10 in HSP active stage may show that in HSP, there is no shift to Th1 lymphocytes in children with HSP. Further investigations are warranted to more fully explore and understand the production of and potential role of these chemokines in HSP.
Literatur
1.
Zurück zum Zitat Cassidy JT, Petty RE (2001) Vasculitis, Henoch-Schonlein purpura. In: Cassidy JT, Petty E (eds) Pediatric rheumatology, 4th edn. Saunders, Philadelphia pp 569–579 Cassidy JT, Petty RE (2001) Vasculitis, Henoch-Schonlein purpura. In: Cassidy JT, Petty E (eds) Pediatric rheumatology, 4th edn. Saunders, Philadelphia pp 569–579
2.
Zurück zum Zitat Leung DY (1990) Immunologic aspects of Kawasaki syndrome. J Rheumatol Suppl 24:15–18PubMed Leung DY (1990) Immunologic aspects of Kawasaki syndrome. J Rheumatol Suppl 24:15–18PubMed
3.
Zurück zum Zitat Cohen TJ, Kallenberg CG (1991) Vasculitis. In: The TH, De Kallenberg CGM, Leij L (eds) Klinische Immunologie. Houten/Antwerpen, Bohn Stafleu Van Loghum, pp 216–233 Cohen TJ, Kallenberg CG (1991) Vasculitis. In: The TH, De Kallenberg CGM, Leij L (eds) Klinische Immunologie. Houten/Antwerpen, Bohn Stafleu Van Loghum, pp 216–233
4.
Zurück zum Zitat Ekenstam EA, Callen JP (1984) Cutaneous leukocytoclastic vasculitis. Clinical and laboratory features of 82 patients seen in private practice. Arch Dermatol 120:484–489CrossRef Ekenstam EA, Callen JP (1984) Cutaneous leukocytoclastic vasculitis. Clinical and laboratory features of 82 patients seen in private practice. Arch Dermatol 120:484–489CrossRef
5.
Zurück zum Zitat McKee PH, Calonje E, Granter SR (2005) Vascular diseases, Leukocytoclastic vasculitis. In: McKee PH, Calonje E, Granter SR (eds) Pathology of the skin, 3rd edn. Mosby, Philadelphia, pp 709–775 McKee PH, Calonje E, Granter SR (2005) Vascular diseases, Leukocytoclastic vasculitis. In: McKee PH, Calonje E, Granter SR (eds) Pathology of the skin, 3rd edn. Mosby, Philadelphia, pp 709–775
6.
Zurück zum Zitat Schall TJ (1994) The chemokines. In: The chemokine handbook, 2nd edn. Academic, New York, pp 419–460 Schall TJ (1994) The chemokines. In: The chemokine handbook, 2nd edn. Academic, New York, pp 419–460
7.
Zurück zum Zitat Ueno Y, Takano N, Kanegane H, Yokoi T, Yachie A, Miyawaki T, Taniguchi N (1989) The acute phase nature of interleukin-6: studies in Kawasaki disease and other febrile illnesses. Clin Exp Immunol 76:337–342PubMed Ueno Y, Takano N, Kanegane H, Yokoi T, Yachie A, Miyawaki T, Taniguchi N (1989) The acute phase nature of interleukin-6: studies in Kawasaki disease and other febrile illnesses. Clin Exp Immunol 76:337–342PubMed
8.
Zurück zum Zitat Kim HS, Kim WD, Lee YH (2003) Production and expression of Groand RANTES by peripheral blood mono nuclear cells isolated from patients with kawasaki disease and measles. J Korean Med Sci 18:381–386PubMedCrossRef Kim HS, Kim WD, Lee YH (2003) Production and expression of Groand RANTES by peripheral blood mono nuclear cells isolated from patients with kawasaki disease and measles. J Korean Med Sci 18:381–386PubMedCrossRef
9.
Zurück zum Zitat Richmond A, Shattuck RL (1966) Melanoma growth stimulatory activity: physiology, biology, structure/function and role in disease. In: Horyk R (ed) Chemoattractant Ligands and their receptors, CRS Press, Boca Raton, pp 87–124 Richmond A, Shattuck RL (1966) Melanoma growth stimulatory activity: physiology, biology, structure/function and role in disease. In: Horyk R (ed) Chemoattractant Ligands and their receptors, CRS Press, Boca Raton, pp 87–124
10.
Zurück zum Zitat Mahanty S, Bausch DG, Thomas RL, Goba A, Bah A, Peters CJ, Rollin PE (2001) Low levels of interleukin-8 and interferon-inducible protein-10 in serum are associated with infections in acute Lassa fever. J Infect Dis 183:1713–1721PubMedCrossRef Mahanty S, Bausch DG, Thomas RL, Goba A, Bah A, Peters CJ, Rollin PE (2001) Low levels of interleukin-8 and interferon-inducible protein-10 in serum are associated with infections in acute Lassa fever. J Infect Dis 183:1713–1721PubMedCrossRef
11.
Zurück zum Zitat Frangogiannis NG, Mendoza LH, Smith CW, Michael LH, Entman ML (2000) Induction of the synthesis of the C-X-C chemokine interferon γ inducible protein-10 in experimental canine endotoxemia. Cell Tissue Res 302:365–376PubMedCrossRef Frangogiannis NG, Mendoza LH, Smith CW, Michael LH, Entman ML (2000) Induction of the synthesis of the C-X-C chemokine interferon γ inducible protein-10 in experimental canine endotoxemia. Cell Tissue Res 302:365–376PubMedCrossRef
12.
Zurück zum Zitat Miotto D, Christodopoulos P, Olivenstein R (2001) Expression of IFN-gamma-inducible protein; monocyte chemotactic proteins 1, 3, and 4; and eotaxin in Th1 and Th2-mediated lung diseases. J Allergy Clin Immunol 107:664–670PubMedCrossRef Miotto D, Christodopoulos P, Olivenstein R (2001) Expression of IFN-gamma-inducible protein; monocyte chemotactic proteins 1, 3, and 4; and eotaxin in Th1 and Th2-mediated lung diseases. J Allergy Clin Immunol 107:664–670PubMedCrossRef
13.
Zurück zum Zitat Borish LC, Steinke JW (2003) Cytokines and chemokines. J Allergy Clin Immunol 111:S460–S475PubMedCrossRef Borish LC, Steinke JW (2003) Cytokines and chemokines. J Allergy Clin Immunol 111:S460–S475PubMedCrossRef
14.
Zurück zum Zitat Luster AD (1998) Chemokines—chemotactic cytokines that mediate inflammation. N Engl J Med 338:436–445PubMedCrossRef Luster AD (1998) Chemokines—chemotactic cytokines that mediate inflammation. N Engl J Med 338:436–445PubMedCrossRef
15.
Zurück zum Zitat Davin JC, Berge IJT, Weenig JJ (2001) What is the difference between IgA nephropathy and Henoch-Schonlein purpura nephritis? Kidney Int 59:823–834PubMedCrossRef Davin JC, Berge IJT, Weenig JJ (2001) What is the difference between IgA nephropathy and Henoch-Schonlein purpura nephritis? Kidney Int 59:823–834PubMedCrossRef
16.
Zurück zum Zitat Chung HS, Kim HY, Kim HS, Lee HJ, Yuh JH, Lee ES, Choi KH, Lee YH (2004) Production of chemokines in Kawasaki disease, Henoch-Schonlein purpura and acute febrile illness. J Korean Med Sci 19:800–804PubMed Chung HS, Kim HY, Kim HS, Lee HJ, Yuh JH, Lee ES, Choi KH, Lee YH (2004) Production of chemokines in Kawasaki disease, Henoch-Schonlein purpura and acute febrile illness. J Korean Med Sci 19:800–804PubMed
17.
Zurück zum Zitat Yang YH, Lai HJ, Huang CM, Wang LC, Lin YT, Chiang BL (2004) Sera from children with active Henoch Schonlein purpura can enhance the production of interleukin 8 by human umblical venous endothelial cells. Ann Rheum Dis 63:1511–1513PubMedCrossRef Yang YH, Lai HJ, Huang CM, Wang LC, Lin YT, Chiang BL (2004) Sera from children with active Henoch Schonlein purpura can enhance the production of interleukin 8 by human umblical venous endothelial cells. Ann Rheum Dis 63:1511–1513PubMedCrossRef
18.
Zurück zum Zitat Amoli MM, Thomson W, Hajeer AH, Calvino MC, Garcia-Porrua C, Ollier WE, Gonzalez-Gay MA (2002) Interleukin 8 gene polymorphism is associated with increased risk of nephritis in cutaneous vasculitis. J Rheumatol 29:2367–2370PubMed Amoli MM, Thomson W, Hajeer AH, Calvino MC, Garcia-Porrua C, Ollier WE, Gonzalez-Gay MA (2002) Interleukin 8 gene polymorphism is associated with increased risk of nephritis in cutaneous vasculitis. J Rheumatol 29:2367–2370PubMed
19.
Zurück zum Zitat Mills JA, Michel BA, Block DA, Calabrese LH, Hunder GG, Arend WP (1990) The American College of Rheumatology 1990 criteria for the classification of Henoch-Schonlein purpura. Arthritis Rheum 33:1114–1121PubMedCrossRef Mills JA, Michel BA, Block DA, Calabrese LH, Hunder GG, Arend WP (1990) The American College of Rheumatology 1990 criteria for the classification of Henoch-Schonlein purpura. Arthritis Rheum 33:1114–1121PubMedCrossRef
20.
Zurück zum Zitat Besbas N, Saatci U, Ruacan S (1997) The role of cytokines in Henoch Schonlein purpura. Scand J Rheumatol 26:456–460PubMed Besbas N, Saatci U, Ruacan S (1997) The role of cytokines in Henoch Schonlein purpura. Scand J Rheumatol 26:456–460PubMed
21.
Zurück zum Zitat Bradley JR, Lockwood CM, Thiru S (1994) Endotheial cell activation in patients with systemic vasculitis. Q J Med 87:741–745 Bradley JR, Lockwood CM, Thiru S (1994) Endotheial cell activation in patients with systemic vasculitis. Q J Med 87:741–745
24.
Zurück zum Zitat Quin S, Rottman JB, Myers N, Kassam N, Weinblatt M, Loetscher M, Koch AE, Moser B, Mackay CR (1998) The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions. J Clin Invest 101:746 Quin S, Rottman JB, Myers N, Kassam N, Weinblatt M, Loetscher M, Koch AE, Moser B, Mackay CR (1998) The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions. J Clin Invest 101:746
25.
Zurück zum Zitat Bandeira-Melo C, Herbst A, Weller PF (2001) Eotaxins contributing to the diversity of eosinophil recruitment and activation. Am J Respir Cell Mol Biol 24:653–657PubMed Bandeira-Melo C, Herbst A, Weller PF (2001) Eotaxins contributing to the diversity of eosinophil recruitment and activation. Am J Respir Cell Mol Biol 24:653–657PubMed
26.
Zurück zum Zitat Teruya-Feldstein J, Jaffe ES, Burd PR, Kingma DW, Setsuda JE, Tosato G (1999) Differential chemokine expression in tissues involved by Hodgkin’s disease: direct correlation of eotaxin expression and tissue eosinophilia. Blood 93:2463–2470PubMed Teruya-Feldstein J, Jaffe ES, Burd PR, Kingma DW, Setsuda JE, Tosato G (1999) Differential chemokine expression in tissues involved by Hodgkin’s disease: direct correlation of eotaxin expression and tissue eosinophilia. Blood 93:2463–2470PubMed
27.
Zurück zum Zitat Garcia-Zepeda EA, Rothenberg ME, Ownbey RT, Celestin J, Leder P, Luster AD (1996) Human eotaxin is a specific chemoattractant for eosinophil cells and provides a new mechanism to explain tissue eosinophilia. Nature Med 97:604–612 Garcia-Zepeda EA, Rothenberg ME, Ownbey RT, Celestin J, Leder P, Luster AD (1996) Human eotaxin is a specific chemoattractant for eosinophil cells and provides a new mechanism to explain tissue eosinophilia. Nature Med 97:604–612
28.
Zurück zum Zitat Ying S, Robinson DS, Meng Q, Barata LT, McEuen AR, Buckley MG, Walls AF, Askenase PW, Kay AB (1999) CC chemokines in allergen induced late phase cutaneous responses in atopic subjects: association of eotaxin with early 6-hour eosinophils and of eotaxin-2 and monocyte chemoattractant protein-4 with the later 24-hour tissue eosinophilia and relationship to basophils and other CC chemokines (monocyte chemoattractant protein-3 and RANTES). J Immunol 163:3976–3984PubMed Ying S, Robinson DS, Meng Q, Barata LT, McEuen AR, Buckley MG, Walls AF, Askenase PW, Kay AB (1999) CC chemokines in allergen induced late phase cutaneous responses in atopic subjects: association of eotaxin with early 6-hour eosinophils and of eotaxin-2 and monocyte chemoattractant protein-4 with the later 24-hour tissue eosinophilia and relationship to basophils and other CC chemokines (monocyte chemoattractant protein-3 and RANTES). J Immunol 163:3976–3984PubMed
29.
Zurück zum Zitat Namgoong MK, Lim BK, Kim JS (1997) Eosinophilic cationic protein in Henoch-Schonlein purpura and IgA nephrophaty. Pediatr Nephrol 11:703–706PubMedCrossRef Namgoong MK, Lim BK, Kim JS (1997) Eosinophilic cationic protein in Henoch-Schonlein purpura and IgA nephrophaty. Pediatr Nephrol 11:703–706PubMedCrossRef
30.
Zurück zum Zitat Kawasaki Y, Hosoya M, Suzuki H (2005) Possible pathogenic role of IL-5 and eosino cationic protein in Henoch-Schonlein purpura nephritis. Pediatr Int 47:512–517PubMedCrossRef Kawasaki Y, Hosoya M, Suzuki H (2005) Possible pathogenic role of IL-5 and eosino cationic protein in Henoch-Schonlein purpura nephritis. Pediatr Int 47:512–517PubMedCrossRef
31.
Zurück zum Zitat Rankin SM, Conroy DM, Williams TJ (2000) Eotaxin and eosinophil recruitment: implications for human disease. Mol Med Today 6:20–27PubMedCrossRef Rankin SM, Conroy DM, Williams TJ (2000) Eotaxin and eosinophil recruitment: implications for human disease. Mol Med Today 6:20–27PubMedCrossRef
32.
Zurück zum Zitat Imai T, Baba M, Nishimura M, Kakizaki M, Takagi S, Yoshie O (1997) The T cell-directed CC chemokine TARC is a highly specific biological ligand for CC chemokine receptor 4. J Biol Chem 272:15036PubMedCrossRef Imai T, Baba M, Nishimura M, Kakizaki M, Takagi S, Yoshie O (1997) The T cell-directed CC chemokine TARC is a highly specific biological ligand for CC chemokine receptor 4. J Biol Chem 272:15036PubMedCrossRef
33.
Zurück zum Zitat Imai T, Takagi S, Nishimura M, Kakizaki M, Nishimura M, Wang J, Gray PW, Matsushima K, Yoshie O (1999) Selective recruitment of CCR4-bearing Th2 cells toward antigen-presenting cells by the CC chemokines thymus and activation-regulated chemokine and macrophage-derived chemokine. Int Immunol 11:81PubMedCrossRef Imai T, Takagi S, Nishimura M, Kakizaki M, Nishimura M, Wang J, Gray PW, Matsushima K, Yoshie O (1999) Selective recruitment of CCR4-bearing Th2 cells toward antigen-presenting cells by the CC chemokines thymus and activation-regulated chemokine and macrophage-derived chemokine. Int Immunol 11:81PubMedCrossRef
34.
Zurück zum Zitat Bonecchi R, Bianchi G, Bordignon PP, D’Ambrosio D, Lang R, Borsatti A, Sozzani S, Allavena P, Gray A, Mantovani A (1998) Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s. J Exp Med 187:129PubMedCrossRef Bonecchi R, Bianchi G, Bordignon PP, D’Ambrosio D, Lang R, Borsatti A, Sozzani S, Allavena P, Gray A, Mantovani A (1998) Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s. J Exp Med 187:129PubMedCrossRef
35.
Zurück zum Zitat Sallusto F, Lenig D, Mackay R, Lanzavecchia A (1998) Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes. J Exp Med 187:875PubMedCrossRef Sallusto F, Lenig D, Mackay R, Lanzavecchia A (1998) Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes. J Exp Med 187:875PubMedCrossRef
36.
Zurück zum Zitat Kakinuma T, Nakamura K, Wakugawa M, Mitsui H, Tada Y, Saeki H (2001) Thymus and activation-regulated chemokine in atopic dermatitis: serum thymus and activation-regulated chemokine level is closely related with disease activity. J Allergy Clin Immunol 107:535–541PubMedCrossRef Kakinuma T, Nakamura K, Wakugawa M, Mitsui H, Tada Y, Saeki H (2001) Thymus and activation-regulated chemokine in atopic dermatitis: serum thymus and activation-regulated chemokine level is closely related with disease activity. J Allergy Clin Immunol 107:535–541PubMedCrossRef
37.
Zurück zum Zitat Leung DYM (2000) Atopic dermatitis: new insights and opportunities for terapotic intervention. J Allergy Clin Immunol 105:860–876PubMedCrossRef Leung DYM (2000) Atopic dermatitis: new insights and opportunities for terapotic intervention. J Allergy Clin Immunol 105:860–876PubMedCrossRef
38.
Zurück zum Zitat Sekiya T, Yamada H, Yamaguchi M, Yamamoto K, Ishii A, Yoshie O, Sano Y, Morita A, Matsushima K, Hirai K (2002) Increased levels of Th2-type CC chemokine thymus and activation-regulated chemokine (TARC) in serum and induced sputum of asthmatics. Allergy 57:173–177PubMedCrossRef Sekiya T, Yamada H, Yamaguchi M, Yamamoto K, Ishii A, Yoshie O, Sano Y, Morita A, Matsushima K, Hirai K (2002) Increased levels of Th2-type CC chemokine thymus and activation-regulated chemokine (TARC) in serum and induced sputum of asthmatics. Allergy 57:173–177PubMedCrossRef
39.
Zurück zum Zitat Medoff BD, Sauty A, Tager AM, Maclean JA, Smith RN, Mathew A, Dufour JH, Luster AD (2002) IFN-γ-inducble protein 10 (CXCL10) contributes to airway hyperreactivity and airway inflammation in a mouse model of asthma. J Immunol 168:5278–5286PubMed Medoff BD, Sauty A, Tager AM, Maclean JA, Smith RN, Mathew A, Dufour JH, Luster AD (2002) IFN-γ-inducble protein 10 (CXCL10) contributes to airway hyperreactivity and airway inflammation in a mouse model of asthma. J Immunol 168:5278–5286PubMed
40.
Zurück zum Zitat Loetscher P, Pellegrino A, Gong JH, Mottioli I, Loetscher M, Bardi G, Baggiolini M, Clark-Lewis I (2001) The ligands of CXC chemokine receptor 3, I-TAC, Mig, and IP-10, are natural antagonists for CCR3. J Biological Chemist 276:2986–2991CrossRef Loetscher P, Pellegrino A, Gong JH, Mottioli I, Loetscher M, Bardi G, Baggiolini M, Clark-Lewis I (2001) The ligands of CXC chemokine receptor 3, I-TAC, Mig, and IP-10, are natural antagonists for CCR3. J Biological Chemist 276:2986–2991CrossRef
42.
Zurück zum Zitat Sallusto F, Mackay CR, Lanzavecchia A (1997) Selective expression of the eotaxin receptor CCR3 by human T helper 2 cells. Science 277:2005PubMedCrossRef Sallusto F, Mackay CR, Lanzavecchia A (1997) Selective expression of the eotaxin receptor CCR3 by human T helper 2 cells. Science 277:2005PubMedCrossRef
43.
Zurück zum Zitat Siveke JT, Hamann A (1998) T helper 1 and T helper 2 cells respond differentially chemokines. J Immunol 160:550PubMed Siveke JT, Hamann A (1998) T helper 1 and T helper 2 cells respond differentially chemokines. J Immunol 160:550PubMed
44.
Zurück zum Zitat Davin DJ, Pierard G, Dechenne C (1994) Possible pathogenic role of IgE in Henoch Schonlein purpura. Pediatr Nephrol 8:169–171PubMedCrossRef Davin DJ, Pierard G, Dechenne C (1994) Possible pathogenic role of IgE in Henoch Schonlein purpura. Pediatr Nephrol 8:169–171PubMedCrossRef
45.
Zurück zum Zitat Davin DJ, Vandenbroek MC, Foidart JB (1985) Sequential measruments of the reticulo-endothelial system function in Henoch-Schonlein disease in childhood. Correlation with various immunological parameters. Acta Paediatr Scand 7:201–206 Davin DJ, Vandenbroek MC, Foidart JB (1985) Sequential measruments of the reticulo-endothelial system function in Henoch-Schonlein disease in childhood. Correlation with various immunological parameters. Acta Paediatr Scand 7:201–206
46.
Zurück zum Zitat Urbanek R, Karitzky D, Kunzer W (1978) Serum IgE bei Hauterkrankungen im Kindersalter. Deutsche Med Wochenschr 103:503–508CrossRef Urbanek R, Karitzky D, Kunzer W (1978) Serum IgE bei Hauterkrankungen im Kindersalter. Deutsche Med Wochenschr 103:503–508CrossRef
47.
Zurück zum Zitat Tsuji Y, Abe Y, Hisano M, Sakai T (2004) Urinary leukotriene E4 in Henoch-Schonlein purpura. Clin Exp Allergy 34:1259–1261PubMedCrossRef Tsuji Y, Abe Y, Hisano M, Sakai T (2004) Urinary leukotriene E4 in Henoch-Schonlein purpura. Clin Exp Allergy 34:1259–1261PubMedCrossRef
Metadaten
Titel
The role of chemokines in Henoch Schonlein Purpura
verfasst von
Fulya Tahan
Ismail Dursun
Hakan Poyrazoglu
Metin Gurgoze
Ruhan Dusunsel
Publikationsdatum
01.08.2007
Verlag
Springer-Verlag
Erschienen in
Rheumatology International / Ausgabe 10/2007
Print ISSN: 0172-8172
Elektronische ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-007-0332-7

Weitere Artikel der Ausgabe 10/2007

Rheumatology International 10/2007 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.